Are Taysha Gene Therapies Inc (NASDAQ: TSHA) Shares Worth Your Money In 2024?

In the latest trading session, 0.92 million Taysha Gene Therapies Inc (NASDAQ:TSHA) shares changed hands as the company’s beta touched 0.49. With the company’s most recent per share price at $3.99 changing hands around $0.02 or 0.50% at last look, the market valuation stands at $746.21M. TSHA’s current price is a discount, trading about -8.27% off its 52-week high of $4.32. The share price had its 52-week low at $0.50, which suggests the last value was 87.47% up since then. When we look at Taysha Gene Therapies Inc’s average trading volume, we note the 3-month average coming to 2.45 million.

Taysha Gene Therapies Inc (NASDAQ:TSHA) trade information

Instantly TSHA is in green as seen in intraday trades today. With action 1.79%, the performance over the past five days has been green. The jump to weekly highs of 4.32 added 0.50% to the stock’s daily price. The company’s shares are showing year-to-date upside of 125.42%, with the 5-day performance at 1.79% in the green. However, in the 30-day time frame, Taysha Gene Therapies Inc (NASDAQ:TSHA) is 27.07% up.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Taysha Gene Therapies Inc (TSHA) estimates and forecasts

Data shows that the Taysha Gene Therapies Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 157.42% over the past 6 months, a 55.21% in annual growth rate that is considerably higher than the industry average of 17.10%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -137.69%. The 2024 estimates are for Taysha Gene Therapies Inc earnings to increase by 56.63%.